Respiratory syncytial virus group-specific antibody response in nasopharyngeal secretions from infants and children after primary infection

scientific article published on July 1994

Respiratory syncytial virus group-specific antibody response in nasopharyngeal secretions from infants and children after primary infection is …
instance of (P31):
scholarly articleQ13442814

External links are
P932PMC publication ID368291
P698PubMed publication ID8556486

P2093author name stringTsutsumi H
Nagai K
Matsuda K
Yamazaki H
Chiba S
Ogra PL
P2860cites workAntigenic relatedness between glycoproteins of human respiratory syncytial virus subgroups A and B: evaluation of the contributions of F and G glycoproteins to immunityQ36919232
Serum and nasal-wash immunoglobulin G and A antibody response of infants and children to respiratory syncytial virus F and G glycoproteins following primary infection.Q37205945
Subgroup characteristics of respiratory syncytial virus strains recovered from children with two consecutive infections.Q37217484
Expression of the F glycoprotein of respiratory syncytial virus by a recombinant vaccinia virus: comparison of the individual contributions of the F and G glycoproteins to host immunityQ37401975
Development of local immunity: role in mechanisms of protection against or pathogenesis of respiratory syncytial viral infectionsQ37822410
Occurrence of respiratory syncytial virus subgroup A and B strains in Japan, 1980 to 1987.Q40193870
The Immunologic Response to Infection with Respiratory Syncytial Virus in InfantsQ40924061
Strain-specific serum antibody responses in infants undergoing primary infection with respiratory syncytial virusQ43443712
Respiratory syncytial virus epidemics: variable dominance of subgroups A and B strains among children, 1981-1986.Q44025021
Experimental respiratory syncytial virus infection of adults. Possible mechanisms of resistance to infection and illnessQ44526388
Identification of a synthetic peptide as part of a major neutralization epitope of respiratory syncytial virusQ44977322
Three antigenic variant groups in human respiratory syncytial virus subgroup B isolated in JapanQ45787138
Secretory Antibody Response to Respiratory Syncytial Virus InfectionQ45791739
Purification and characterization of GP90, one of the envelope glycoproteins of respiratory syncytial virusQ45794683
Epidemiology of respiratory syncytial virus infection in Washington, D.C. I. Importance of the virus in different respiratory tract disease syndromes and temporal distribution of infectionQ45819346
Antigenic variation between human respiratory syncytial virus isolatesQ45831009
Antigenic characterization of respiratory syncytial virus strains with monoclonal antibodiesQ45844409
Two distinct subtypes of human respiratory syncytial virusQ45848624
Group-specific serum antibody responses in children with primary and recurrent respiratory syncytial virus infectionsQ45852624
Respiratory-syncytial-virus infections, reinfections and immunity. A prospective, longitudinal study in young childrenQ45888997
Antigenic variation of human RSV strains isolated in JapanQ69055901
The use of gowns and masks to control respiratory illness in pediatric hospital personnelQ70978141
P433issue4
P304page(s)469-472
P577publication date1994-07-01
P1433published inClinical and Vaccine ImmunologyQ5133811
P1476titleRespiratory syncytial virus group-specific antibody response in nasopharyngeal secretions from infants and children after primary infection
P478volume1

Reverse relations

cites work (P2860)
Q35224466Development of interleukin 6 and tumor necrosis factor alpha activity in nasopharyngeal secretions of infants and children during infection with respiratory syncytial virus
Q37071608Pulmonary immunity and immunopathology: lessons from respiratory syncytial virus.
Q39127064The Human Immune Response to Respiratory Syncytial Virus Infection

Search more.